Related Articles
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma
Paclitaxel for relapsed small‑cell lung cancer patients with idiopathic interstitial pneumonias
Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer
Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer
A phase II study of S‑1 in relapsed small cell lung cancer